Syncona Limited Total Liabilities

Latest as of September 2025: GBX13.77 Million GBX ≈ $1.68K USD

Syncona Limited total liabilities. Based on the latest financial reports, Syncona Limited (SYNC) has total liabilities worth GBX13.77 Million GBX (≈ $1.68K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SYNC financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Syncona Limited (2013–2025)

Total liabilities of Syncona Limited from 2013 to 2025. This chart illustrates how Syncona Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Syncona Limited (SYNC) investment intensity to see how much of total assets are deployed in long-term investments.

Syncona Limited Competitors by Total Liabilities

The table below lists competitors of Syncona Limited ranked by their total liabilities.

Company Country Total Liabilities
Xenora Minerals Ltd
AU:XRA
Australia AU$671.26K
AEON Biopharma, Inc.
NYSE MKT:AEON
USA $28.61 Million
Marine Petroleum Trust
NASDAQ:MARPS
USA $0.00
Yonga Mobilya Sanayi ve Ticaret AS
IS:YONGA
Turkey TL36.37 Million
Daekyo Co Ltd
KO:019685
Korea ₩297.83 Billion
NextPoint Capital SOCIMI S.A.
MC:YNPC
Spain €73.15 Million
Bawat Water Technologies AB
ST:BAWAT
Sweden Skr28.66 Million
Bright Packaging Industry Bhd
KLSE:9938
Malaysia RM8.36 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Syncona Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Syncona Limited assets under control.

Liquidity & Leverage Metrics

Syncona Limited Total Liabilities Ratios Explained

Syncona Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.02 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.01 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.01 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Syncona Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Syncona Limited (2013–2025)

The table below shows the annual total liabilities of Syncona Limited from 2013 to 2025.

Year Total Liabilities Change
2025-03-31 GBX11.79 Million
≈ $1.44K
-3.47%
2024-03-31 GBX12.22 Million
≈ $1.49K
-11.18%
2023-03-31 GBX13.76 Million
≈ $1.67K
-41.57%
2022-03-31 GBX23.55 Million
≈ $2.86K
-38.23%
2021-03-31 GBX38.12 Million
≈ $4.64K
+25.76%
2020-03-31 GBX30.31 Million
≈ $3.69K
+26.88%
2019-03-31 GBX23.89 Million
≈ $2.91K
+57.33%
2018-03-31 GBX15.18 Million
≈ $1.85K
+148.59%
2017-03-31 GBX6.11 Million
≈ $743.17
+25.04%
2016-03-31 GBX4.88 Million
≈ $594.36
+7.41%
2015-03-31 GBX4.55 Million
≈ $553.36
+30.54%
2014-03-31 GBX3.48 Million
≈ $423.90
+209.69%
2013-03-31 GBX1.12 Million
≈ $136.88
--

About Syncona Limited

LSE:SYNC UK Asset Management
Market Cap
$9.03 Million
GBX74.20 Billion GBX
Market Cap Rank
#27199 Global
#369 in UK
Share Price
GBX122.00
Change (1 day)
-2.09%
52-Week Range
GBX86.90 - GBX129.00
All Time High
GBX302.47
About

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and… Read more